nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins
|
Vignoli, Alfonso |
|
2018 |
97 |
9 |
p. 1555-1562 |
artikel |
2 |
A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion
|
Miao, Yuqing |
|
2018 |
97 |
9 |
p. 1663-1669 |
artikel |
3 |
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence
|
Orvain, Corentin |
|
2018 |
97 |
9 |
p. 1601-1609 |
artikel |
4 |
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
|
Cattaneo, C. |
|
2018 |
97 |
9 |
p. 1717-1726 |
artikel |
5 |
Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature
|
Timmers, Nyanza K. L. M. |
|
2018 |
97 |
9 |
p. 1627-1632 |
artikel |
6 |
Copper deficiency: a cause of misdiagnosis of myelodysplastic syndrome
|
Villalba, Ana |
|
2018 |
97 |
9 |
p. 1737-1738 |
artikel |
7 |
Copper deficiency anemia: review article
|
Myint, Zin W. |
|
2018 |
97 |
9 |
p. 1527-1534 |
artikel |
8 |
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
|
Egle, Alexander |
|
2018 |
97 |
9 |
p. 1745 |
artikel |
9 |
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
|
Katodritou, Eirini |
|
2018 |
97 |
9 |
p. 1747 |
artikel |
10 |
Correction to: The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study
|
Forbrigger, Zara |
|
2018 |
97 |
9 |
p. 1743 |
artikel |
11 |
Distinctive CD8+ T cell and MHC class I signatures in polycythemia vera patients
|
Cardoso, Elsa M. |
|
2018 |
97 |
9 |
p. 1563-1575 |
artikel |
12 |
Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease
|
Dong, Yujun |
|
2018 |
97 |
9 |
p. 1641-1647 |
artikel |
13 |
Effects of post-remission chemotherapy before allo-HSCT for acute myeloid leukemia during first complete remission: a meta-analysis
|
Zhu, Yangmin |
|
2018 |
97 |
9 |
p. 1519-1526 |
artikel |
14 |
Efficacy of decitabine as hemoglobin F inducer in HbE/β-thalassemia
|
Kalantri, Siddhesh Arun |
|
2018 |
97 |
9 |
p. 1689-1694 |
artikel |
15 |
Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A
|
Kim, Hyun-Young |
|
2018 |
97 |
9 |
p. 1695-1700 |
artikel |
16 |
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
|
Hatta, Yoshihiro |
|
2018 |
97 |
9 |
p. 1535-1545 |
artikel |
17 |
− 174 G>C IL-6 polymorphism and primary iron overload in male patients
|
Tetzlaff, Walter F. |
|
2018 |
97 |
9 |
p. 1683-1687 |
artikel |
18 |
Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma
|
Sorigue, Marc |
|
2018 |
97 |
9 |
p. 1633-1640 |
artikel |
19 |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation
|
Qu, Mingming |
|
2018 |
97 |
9 |
p. 1701-1706 |
artikel |
20 |
Massive hemolysis complicating acute granulomatous hepatitis
|
Carpio, Adrià |
|
2018 |
97 |
9 |
p. 1741-1742 |
artikel |
21 |
Mott cell interstitial nephritis revealing Waldenström macroglobulinaemia
|
Moktefi, Anissa |
|
2018 |
97 |
9 |
p. 1735-1736 |
artikel |
22 |
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice
|
Breccia, Massimo |
|
2018 |
97 |
9 |
p. 1577-1580 |
artikel |
23 |
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
|
Katodritou, Eirini |
|
2018 |
97 |
9 |
p. 1671-1682 |
artikel |
24 |
Re-treatment versus extended treatment strategy of systemic bevacizumab in hereditary hemorrhagic telangiectasia: which is better?
|
Epperla, Narendranath |
|
2018 |
97 |
9 |
p. 1727-1729 |
artikel |
25 |
Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial
|
Griesshammer, Martin |
|
2018 |
97 |
9 |
p. 1591-1600 |
artikel |
26 |
Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients
|
Allain, Eric P. |
|
2018 |
97 |
9 |
p. 1649-1661 |
artikel |
27 |
SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation
|
Kim, Jieun |
|
2018 |
97 |
9 |
p. 1731-1734 |
artikel |
28 |
Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to l-asparaginase
|
Watanabe, Junko |
|
2018 |
97 |
9 |
p. 1739-1740 |
artikel |
29 |
The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
|
Hong, Yan |
|
2018 |
97 |
9 |
p. 1547-1554 |
artikel |
30 |
The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders
|
Takanashi, Satoshi |
|
2018 |
97 |
9 |
p. 1611-1618 |
artikel |
31 |
The WHO diagnostic criteria for polycythemia vera—role of red cell mass versus hemoglobin/hematocrit level and morphology
|
Jakovic, Ljubomir |
|
2018 |
97 |
9 |
p. 1581-1590 |
artikel |
32 |
Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies
|
Tawfik, Bernard |
|
2018 |
97 |
9 |
p. 1707-1716 |
artikel |
33 |
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
|
Ciochetto, Chiara |
|
2018 |
97 |
9 |
p. 1619-1626 |
artikel |